Yu‐Pei Yuan

2.9k total citations · 2 hit papers
31 papers, 2.4k citations indexed

About

Yu‐Pei Yuan is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Yu‐Pei Yuan has authored 31 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 17 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Yu‐Pei Yuan's work include Cardiac Fibrosis and Remodeling (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers) and Adipose Tissue and Metabolism (6 papers). Yu‐Pei Yuan is often cited by papers focused on Cardiac Fibrosis and Remodeling (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers) and Adipose Tissue and Metabolism (6 papers). Yu‐Pei Yuan collaborates with scholars based in China, United States and Poland. Yu‐Pei Yuan's co-authors include Zhen‐Guo Ma, Xin Zhang, Qizhu Tang, Si‐Chi Xu, Chun‐Yan Kong, Hai‐Ming Wu, Peng Song, Can Hu, Wei Deng and Qi‐Zhu Tang and has published in prestigious journals such as Nature Communications, Free Radical Biology and Medicine and Diabetologia.

In The Last Decade

Yu‐Pei Yuan

30 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT

2019 359 citations Xin Zhang, Can Hu et al. Cell Death and Differentiation profile →
Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death

2021 226 citations Chun‐Yan Kong, Zhen Guo et al. International Journal of Biological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu‐Pei Yuan China	23	1.2k	1.2k	358	356	322	31	2.4k
Si‐Chi Xu China	20	874 0.7×	930 0.8×	285 0.8×	260 0.7×	305 0.9×	28	1.9k
Rongxue Wu United States	21	720 0.6×	1.0k 0.9×	323 0.9×	334 0.9×	250 0.8×	48	2.4k
Qi‐Zhu Tang China	24	740 0.6×	936 0.8×	276 0.8×	290 0.8×	232 0.7×	47	1.9k
Chun‐Yan Kong China	19	735 0.6×	963 0.8×	276 0.8×	283 0.8×	241 0.7×	31	1.8k
Alessandra Ghigo Italy	30	1.0k 0.9×	1.3k 1.1×	175 0.5×	441 1.2×	361 1.1×	86	2.9k
Can Hu China	18	603 0.5×	814 0.7×	298 0.8×	204 0.6×	320 1.0×	31	1.6k
Bo Ding China	27	618 0.5×	1.5k 1.3×	372 1.0×	260 0.7×	193 0.6×	110	2.5k
Iván P. Uray United States	20	475 0.4×	1.3k 1.2×	267 0.7×	434 1.2×	404 1.3×	40	2.3k
Fumi Takahashi‐Yanaga Japan	32	806 0.7×	2.1k 1.8×	309 0.9×	639 1.8×	149 0.5×	89	3.3k

Countries citing papers authored by Yu‐Pei Yuan

Since Specialization

Citations

This map shows the geographic impact of Yu‐Pei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Pei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Pei Yuan more than expected).

Fields of papers citing papers by Yu‐Pei Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Pei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Pei Yuan. The network helps show where Yu‐Pei Yuan may publish in the future.

Co-authorship network of co-authors of Yu‐Pei Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Pei Yuan. A scholar is included among the top collaborators of Yu‐Pei Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Pei Yuan. Yu‐Pei Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Yu‐Pei, Shi‐Hong Luo, Zhiyong Zheng, et al.. (2025). Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: a phase II multicenter clinical trial. Radiation Oncology. 20(1). 58–58. 1 indexed citations

Yuan, Yu‐Pei, Wenqing Wang, Nan Bi, et al.. (2025). Macrophage pyroptosis promotes cardiac fibroblast activation and myocardial fibrosis via the Hedgehog signaling pathway in radiation-induced heart damage. Journal of Radiation Research and Applied Sciences. 18(3). 101614–101614.

Yuan, Yu‐Pei, Si‐Chi Xu, Chun‐Yan Kong, et al.. (2024). S100a8/9 (S100 Calcium Binding Protein a8/9) Promotes Cardiac Hypertrophy Via Upregulation of FGF23 (Fibroblast Growth Factor 23) in Mice. Journal of the American Heart Association. 13(10). e028006–e028006. 2 indexed citations

Chen, Junyu, Yu‐Pei Yuan, Ying Hu, & Liang Liang. (2024). Lack of Efficacy of Simvastatin Adjunctive Therapy for Patients with Schizophrenia: A Meta-Analysis of Randomized Controlled Trials. Neuropsychiatric Disease and Treatment. Volume 20. 1667–1675. 1 indexed citations

Zhang, Xin, Can Hu, Zhen‐Guo Ma, et al.. (2023). Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice. Nature Communications. 14(1). 3383–3383. 44 indexed citations

Kong, Chun‐Yan, Zhen Guo, Peng Song, et al.. (2021). Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death. International Journal of Biological Sciences. 18(2). 760–770. 226 indexed citations breakdown →

Zhang, Xin, Can Hu, Yu‐Pei Yuan, et al.. (2021). Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism. Cell Biology and Toxicology. 37(6). 873–890. 69 indexed citations

Hu, Can, Xin Zhang, Peng Song, et al.. (2020). Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway. Redox Biology. 37. 101747–101747. 181 indexed citations

Song, Peng, Zhi‐Gang She, Yanyan Meng, et al.. (2020). Geniposide protects against sepsis-induced myocardial dysfunction through AMPKα-dependent pathway. Free Radical Biology and Medicine. 152. 186–196. 61 indexed citations

10.

Ma, Zhen‐Guo, Chun‐Yan Kong, Hai‐Ming Wu, et al.. (2020). Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice. Theranostics. 10(24). 11013–11025. 42 indexed citations

11.

Zhang, Xin, Can Hu, Yu‐Pei Yuan, Zhen‐Guo Ma, & Qizhu Tang. (2020). A brief overview about the physiology of fibronectin type III domain-containing 5. Cellular Signalling. 76. 109805–109805. 17 indexed citations

12.

Zhang, Xin, Can Hu, Chun‐Yan Kong, et al.. (2019). FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death and Differentiation. 27(2). 540–555. 359 indexed citations breakdown →

13.

Zhang, Xin, Jinxiu Zhu, Zhen‐Guo Ma, et al.. (2019). Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity. International Journal of Biological Sciences. 15(3). 556–567. 114 indexed citations

14.

Zhang, Xin, Zhen‐Guo Ma, Yu‐Pei Yuan, et al.. (2018). Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKα/Smad3 signaling. Cell Death and Disease. 9(2). 102–102. 120 indexed citations

15.

Ma, Zhen‐Guo, Chun‐Yan Kong, Peng Song, et al.. (2018). Geniposide Protects against Obesity‐Related Cardiac Injury through AMPKα‐ and Sirt1‐Dependent Mechanisms. Oxidative Medicine and Cellular Longevity. 2018(1). 6053727–6053727. 35 indexed citations

16.

Ma, Zhen‐Guo, Yu‐Pei Yuan, Hai‐Ming Wu, Xin Zhang, & Qizhu Tang. (2018). Cardiac fibrosis: new insights into the pathogenesis. International Journal of Biological Sciences. 14(12). 1645–1657. 252 indexed citations

17.

Ma, Zhen‐Guo, Yu‐Pei Yuan, Xin Zhang, et al.. (2018). C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice. Cardiovascular Research. 115(6). 1067–1077. 76 indexed citations

18.

Ma, Zhen‐Guo, Yu‐Pei Yuan, Xin Zhang, et al.. (2017). Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways. EBioMedicine. 18. 179–187. 124 indexed citations

19.

Ma, Zhen‐Guo, Yu‐Pei Yuan, Si‐Chi Xu, et al.. (2017). CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats. Diabetologia. 60(6). 1126–1137. 138 indexed citations

20.

Li, Jing, Yu‐Pei Yuan, Si‐Chi Xu, et al.. (2017). Arctiin protects against cardiac hypertrophy through inhibiting MAPKs and AKT signaling pathways. Journal of Pharmacological Sciences. 135(3). 97–104. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact